Arcutis Biotherapeutics (ARQT) stock: insider trades, news & valuation
Heavy selling
Close · Oct 9, 2026
$26.58
+8.5% on the day
+28.3% over 12 months
52-week range $19.50 – $31.20
Share price and insider trades
ARQT closeInsider buyInsider sale
Bought, 12 months$0
Sold, 12 months$16.2M
Insiders buying0
Insiders selling11
Arcutis Biotherapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 11 sold $16.2M of ARQT stock on the open market.
Get emailed when insiders cluster-buy stocks like ARQT
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ARQT insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $2.3M | 14 |
| Q2 2026 | — | 0 | $969K | 12 |
| Q1 2026 | — | 0 | $5.4M | 26 |
| Q4 2025 | — | 0 | $8.7M | 32 |
Valuation, profit and volume
P/E (trailing)n/aSector median —
Market value—
Profit margin—Revenue growth —
Volume vs. 50-day0.9×Last 5 sessions
Insiders' paper profit—On all tracked purchases —
Summary
Over the past 12 months, 0 Arcutis Biotherapeutics, Inc. insiders reported open-market purchases totaling $0, while 11 insiders reported sales totaling $16.2M. 75 of 84 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ARQT earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 5, 2026 | -5.4% | Sold $299K | +1.5%S&P -0.4% | -9.6% |
| Feb 25, 2026 | +0.4% | Sold $2.2M | +5.9%S&P +0.3% | -25.7% |
| Oct 28, 2025 | -2.0% | Sold $1.2M | +28.8%S&P +0.3% | +21.2% |
| Aug 6, 2025 | +6.9% | None | -7.9%S&P +0.7% | +21.5% |
| May 6, 2025 | +18.4% | None | -11.1%S&P -0.4% | +4.9% |
| Feb 25, 2025 | +6.7% | None | +6.7%S&P -0.4% | +19.0% |
| Jan 13, 2025 | -7.5% | None | -3.8%S&P +0.3% | -7.3% |
| Nov 6, 2024 | +11.9% | None | +11.8%S&P +3.3% | +19.2% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 18SEC | Masaru MatsudaSee Remarks | Sell Plan | 3,674112,508 held (−3%) | $25.00 | $92K | +6.3% | — |
| Sep 17SEC | Howard G. WelgusDirector | Sell Plan | 4,73035,841 held (−12%) | $24.18 | $114K | +9.9% | — |
| Sep 10SEC | Masaru MatsudaSee Remarks | Sell Plan | 9,989116,182 held (−8%) | $25.03 | $250K | +6.2% | — |
| Aug 28SEC | Terrie CurranDirector | Sell | 27,05223,526 held (−53%) | $25.03 | $677K | +6.2% | — |
| Aug 28SEC | Terrie CurranDirector | Sell | 11,14823,526 held (−32%) | $25.03 | $279K | +6.2% | — |
| Aug 24SEC | Terrie CurranDirector | Sell | 1,07223,526 held (−4%) | $26.04 | $28K | +2.1% | — |
| Aug 21SEC | Patrick BurnettSee Remarks | Sell | 1,697117,592 held (−1%) | $27.00 | $46K | -1.6% | — |
| Aug 19SEC | Howard G. WelgusDirector | Sell Plan | 4,73036,475 held (−11%) | $26.18 | $124K | +1.5% | — |
| Aug 13SEC | Patrick BurnettSee Remarks | Sell | 8,300119,289 held (−7%) | $26.52 | $220K | +0.2% | — |
| Aug 13SEC | Patrick BurnettSee Remarks | Sell | 6,700119,289 held (−5%) | $26.08 | $175K | +1.9% | — |
| Aug 5SEC | Todd WatanabeSee Remarks | Sell Plan | 4,375717,203 held (−1%) | $26.12 | $114K | +1.8% | — |
| Aug 5SEC | Masaru MatsudaSee Remarks | Sell Plan | 1,230126,171 held (−1%) | $26.12 | $32K | +1.8% | — |
| Aug 5SEC | Patrick BurnettSee Remarks | Sell Plan | 955119,289 held (−1%) | $26.12 | $25K | +1.8% | — |
| Jul 17SEC | Howard G. WelgusDirector | Sell Plan | 4,73037,109 held (−11%) | $26.91 | $127K | -1.2% | — |
| Jun 17SEC | Sue-jean LinDirector | Sell Plan | 4,94627,567 held (−15%) | $24.38 | $121K | +9.0% | — |
| Jun 17SEC | Howard G. WelgusDirector | Sell Plan | 4,09638,378 held (−10%) | $24.41 | $100K | +8.9% | — |
| Jun 17SEC | Howard G. WelgusDirector | Sell Plan | 63537,743 held (−2%) | $25.67 | $16K | +3.5% | — |
| May 13SEC | Latha VairavanCFO | Sell Plan | 43585,978 held (−1%) | $21.05 | $9K | +26.3% | — |
| May 13SEC | Patrick BurnettSee Remarks | Sell Plan | 222120,244 held (−0%) | $21.05 | $5K | +26.3% | — |
| May 6SEC | Masaru MatsudaSee Remarks | Sell Plan | 7,372127,573 held (−5%) | $23.27 | $172K | +14.2% | — |
| May 6SEC | Todd WatanabeSee Remarks | Sell Plan | 3,172720,755 held (−0%) | $23.61 | $75K | +12.6% | — |
| May 6SEC | Latha VairavanCFO | Sell Plan | 1,34186,413 held (−2%) | $23.61 | $32K | +12.6% | — |
| May 6SEC | Masaru MatsudaSee Remarks | Sell Plan | 884126,689 held (−1%) | $23.61 | $21K | +12.6% | — |
| May 6SEC | Patrick BurnettSee Remarks | Sell Plan | 684120,466 held (−1%) | $23.61 | $16K | +12.6% | — |
| May 5SEC | Howard G. WelgusDirector | Sell Plan | 7,14432,600 held (−18%) | $22.99 | $164K | +15.6% | — |
| Apr 3SEC | Howard G. WelgusDirector | Sell Plan | 10,00039,744 held (−20%) | $23.88 | $239K | +11.3% | — |
| Mar 4SEC | Keith R LeonardDirector | Sell Plan | 39,27222,123 held (−64%) | $25.39 | $997K | +4.7% | — |
| Mar 4SEC | Howard G. WelgusDirector | Sell Plan | 10,00049,744 held (−17%) | $25.65 | $256K | +3.6% | — |
| Mar 3SEC | Todd WatanabeSee Remarks | Sell Plan | 36,281787,025 held (−4%) | $25.16 | $913K | +5.6% | — |
| Mar 3SEC | Masaru MatsudaSee Remarks | Sell Plan | 6,553137,125 held (−5%) | $25.16 | $165K | +5.6% | — |
| Mar 3SEC | Patrick BurnettSee Remarks | Sell Plan | 6,106121,295 held (−5%) | $25.16 | $154K | +5.6% | — |
| Mar 3SEC | Masaru MatsudaSee Remarks | Sell Plan | 3,325143,678 held (−2%) | $27.95 | $93K | -4.9% | — |
| Mar 3SEC | Larry Todd EdwardsSee Remarks | Sell Plan | 3,584175,281 held (−2%) | $25.16 | $90K | +5.6% | — |
| Mar 3SEC | Latha VairavanCFO | Sell Plan | 2,77287,835 held (−3%) | $25.16 | $70K | +5.6% | — |
| Mar 3SEC | Masaru MatsudaSee Remarks | Sell Plan | 1,987136,932 held (−1%) | $25.70 | $51K | +3.4% | — |
| Mar 3SEC | Todd WatanabeSee Remarks | Sell Plan | 1,068785,957 held (−0%) | $25.91 | $28K | +2.6% | — |
| Mar 3SEC | Masaru MatsudaSee Remarks | Sell Plan | 193136,932 held (−0%) | $25.91 | $5K | +2.6% | — |
| Mar 3SEC | Patrick BurnettSee Remarks | Sell Plan | 181121,150 held (−0%) | $25.91 | $5K | +2.6% | — |
| Mar 3SEC | Larry Todd EdwardsSee Remarks | Sell Plan | 103175,178 held (−0%) | $25.91 | $3K | +2.6% | — |
| Mar 3SEC | Latha VairavanCFO | Sell Plan | 8187,754 held (−0%) | $25.91 | $2K | +2.6% | — |
| Feb 4SEC | Todd WatanabeSee Remarks | Sell Plan | 19,833721,306 held (−3%) | $25.50 | $506K | +4.2% | — |
| Feb 4SEC | Masaru MatsudaSee Remarks | Sell Plan | 19,379114,717 held (−14%) | $25.24 | $489K | +5.3% | — |
| Feb 4SEC | Patrick BurnettSee Remarks | Sell Plan | 9,79480,651 held (−11%) | $25.81 | $253K | +3.0% | — |
| Feb 4SEC | Howard G. WelgusDirector | Sell Plan | 10,00059,744 held (−14%) | $25.05 | $250K | +6.1% | — |
| Feb 4SEC | Masaru MatsudaSee Remarks | Sell Plan | 8,562134,096 held (−6%) | $24.97 | $214K | +6.4% | — |
| Feb 4SEC | Masaru MatsudaSee Remarks | Sell Plan | 7,983142,658 held (−5%) | $25.50 | $204K | +4.2% | — |
| Feb 4SEC | Masaru MatsudaSee Remarks | Sell Plan | 4,714110,003 held (−4%) | $25.63 | $121K | +3.7% | — |
| Feb 4SEC | Patrick BurnettSee Remarks | Sell Plan | 3,67590,445 held (−4%) | $25.50 | $94K | +4.2% | — |
| Feb 4SEC | Larry Todd EdwardsSee Remarks | Sell Plan | 2,052148,865 held (−1%) | $25.50 | $52K | +4.2% | — |
| Feb 4SEC | Latha VairavanCFO | Sell Plan | 1,32063,607 held (−2%) | $25.50 | $34K | +4.2% | — |
| Jan 7SEC | Patrick BurnettSee Remarks | Sell Plan | 2,49094,120 held (−3%) | $28.98 | $72K | -8.3% | — |
| Jan 6SEC | Howard G. WelgusDirector | Sell Plan | 10,00069,744 held (−13%) | $28.96 | $290K | -8.2% | — |
| Jan 2SEC | Patrick BurnettSee Remarks | Sell Plan | 1,15696,610 held (−1%) | $29.39 | $34K | -9.6% | — |
| Jan 2SEC | Patrick BurnettSee Remarks | Sell Plan | 54197,766 held (−1%) | $28.81 | $16K | -7.7% | — |
| Dec 17SEC | Patrick BurnettSee Remarks | Sell Plan | 11,50098,307 held (−10%) | $28.94 | $333K | -8.2% | — |
| Dec 3SEC | Howard G. WelgusDirector | Sell Plan | 10,00079,744 held (−11%) | $30.21 | $302K | -12.0% | — |
| Dec 3SEC | Masaru MatsudaSee Remarks | Sell Plan | 1,657150,641 held (−1%) | $30.23 | $50K | -12.1% | — |
| Nov 25SEC | Sue-jean LinDirector | Sell | 25,27226,735 held (−49%) | $30.78 | $778K | -13.6% | — |
| Nov 24SEC | Todd WatanabeSee Remarks | Sell Plan | 48,945740,537 held (−6%) | $30.36 | $1.5M | -12.5% | — |
| Nov 24SEC | Todd WatanabeSee Remarks | Sell Plan | 1,055793,838 held (−0%) | $30.00 | $32K | -11.4% | — |
| Nov 21SEC | Halley E GilbertDirector | Sell | 16,53222,123 held (−43%) | $27.55 | $455K | -3.5% | — |
| Nov 21SEC | Masaru MatsudaSee Remarks | Sell Plan | 1,561151,476 held (−1%) | $28.50 | $44K | -6.7% | — |
| Nov 21SEC | Masaru MatsudaSee Remarks | Sell Plan | 989153,037 held (−1%) | $27.95 | $28K | -4.9% | — |
| Nov 17SEC | Neha KrishnamohanDirector | Sell Plan | 39,27223,355 held (−63%) | $23.19 | $911K | +14.6% | — |
| Nov 17SEC | Neha KrishnamohanDirector | Sell Plan | 1,23222,123 held (−5%) | $23.37 | $29K | +13.7% | — |
| Nov 10SEC | Larry Todd EdwardsSee Remarks | Sell | 29,131150,193 held (−16%) | $25.16 | $733K | +5.6% | — |
| Nov 10SEC | Patrick BurnettSee Remarks | Sell Plan | 17,25098,325 held (−15%) | $24.18 | $417K | +9.9% | — |
| Nov 5SEC | Todd WatanabeSee Remarks | Sell Plan | 11,478794,962 held (−1%) | $24.71 | $284K | +7.6% | — |
| Nov 5SEC | Howard G. WelgusDirector | Sell Plan | 10,00089,744 held (−10%) | $25.27 | $253K | +5.2% | — |
| Nov 5SEC | Masaru MatsudaSee Remarks | Sell Plan | 7,165154,069 held (−4%) | $24.71 | $177K | +7.6% | — |
| Nov 5SEC | Patrick BurnettSee Remarks | Sell Plan | 3,86498,325 held (−4%) | $23.72 | $92K | +12.1% | — |
| Nov 5SEC | Patrick BurnettSee Remarks | Sell Plan | 2,607102,204 held (−2%) | $24.71 | $64K | +7.6% | — |
| Nov 5SEC | Latha VairavanCFO | Sell Plan | 8864,927 held (−0%) | $24.72 | $2K | +7.5% | — |
| Nov 5SEC | Todd WatanabeSee Remarks | Sell Plan | 69794,893 held (−0%) | $25.40 | $2K | +4.6% | — |
| Nov 5SEC | Masaru MatsudaSee Remarks | Sell Plan | 43154,026 held (−0%) | $25.40 | $1K | +4.6% | — |
| Nov 5SEC | Patrick BurnettSee Remarks | Sell Plan | 15102,189 held (−0%) | $25.40 | $381 | +4.6% | — |
| Oct 30SEC | Todd WatanabeSee Remarks | Sell Plan | 40,000806,440 held (−5%) | $25.03 | $1.0M | +6.2% | — |
| Oct 6SEC | Larry Todd EdwardsSee Remarks | Sell Plan | 4,207178,897 held (−2%) | $19.99 | $84K | +33.0% | — |
| Oct 6SEC | Larry Todd EdwardsSee Remarks | Sell Plan | 297179,324 held (−0%) | $20.78 | $6K | +27.9% | — |
| Oct 3SEC | Todd WatanabeSee Remarks | Sell Plan | 20,739846,440 held (−2%) | $20.04 | $416K | +32.6% | — |
| Oct 3SEC | Todd WatanabeSee Remarks | Sell Plan | 15,000876,440 held (−2%) | $18.91 | $284K | +40.6% | — |
| Oct 3SEC | Todd WatanabeSee Remarks | Sell Plan | 9,261867,179 held (−1%) | $20.02 | $185K | +32.8% | — |
| Oct 3SEC | Howard G. WelgusDirector | Sell Plan | 9,538100,206 held (−9%) | $18.92 | $180K | +40.5% | — |
| Oct 3SEC | Howard G. WelgusDirector | Sell Plan | 46299,744 held (−0%) | $18.92 | $9K | +40.5% | — |
Insiders at Arcutis Biotherapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Todd WatanabeSee Remarks | — | $5.3M | Aug 5, 2026 | — |
| Howard G. WelgusDirector | — | $2.4M | Sep 17, 2026 | — |
| Masaru MatsudaSee Remarks | — | $2.2M | Sep 18, 2026 | — |
| Patrick BurnettSee Remarks | — | $2.0M | Aug 21, 2026 | — |
| Keith R LeonardDirector | — | $997K | Mar 4, 2026 | — |
| Terrie CurranDirector | — | $984K | Aug 28, 2026 | — |
| Larry Todd EdwardsSee Remarks | — | $968K | Mar 3, 2026 | — |
| Neha KrishnamohanDirector | — | $940K | Nov 17, 2025 | — |
| Sue-jean LinDirector | — | $898K | Jun 17, 2026 | — |
| Halley E GilbertDirector | — | $455K | Nov 21, 2025 | — |
| Latha VairavanCFO | — | $148K | May 13, 2026 | — |
ARQT stock: common questions
Are Arcutis Biotherapeutics, Inc. insiders buying ARQT stock?
In the past 12 months, 0 insiders reported open-market purchases of ARQT worth $0.
Are Arcutis Biotherapeutics, Inc. insiders selling ARQT stock?
11 insiders reported sales worth $16.2M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ARQT's 52-week range?
Over the past year ARQT has traded between $19.50 and $31.20. It last closed at $26.58 on Oct 9, 2026.